ECT Safety Reclassification: Psych Rights to FDA
Psych Rights to FDA on the 2016 ECT device safety reclassification.
Psych Rights to FDA on the 2016 ECT device safety reclassification.
Linda Andre on behalf of the Committee for Truth in Psychiatry to the FDA, 2016 ECT device reclassification.
Psychiatrist Daniel P. Fisher to the FDA on the ECT device reclassifications, 2011.
It’s important to report unexpected ECT side effects to the FDA. Our guide will show you how using MedWatch.
We are attorneys with a public agency concerned with mental health issues in New York State, and in that context write this letter in opposition to the above-docketed proposal to reclassify from Class Ill to Class Il devices used to administer electro-convulsive therapy (“ECT”, also commonly referred to as electro-shock or shock treatment).
Depression and Bipolar Support Alliance (DBSA) on ECT device safety reclassification.
Forced insulin coma and electroshock survivor Leonard Roy Frank shares his perspectives with the FDA on ECT device safety reclassification.
Nebraska Advocacy Services, Inc., The Center for Disability Rights, Law, and Advocacy, supports the continued categorization of electroconvulsive therapy (ECT) machines as Class III devices.